Nitric oxide delivery platforms derived from a photoactivatable Mn(II) nitrosyl complex: Entry to photopharmacology

Stable Bimetallic FeII/{Fe(NO)2}9 Moiety Derived from Reductive Transformations of a Diferrous-dinitrosyl Species

A dimeric dithiolate-bridged species, [Fe(NO)(PS2)]₂ (1) containing two {FeNO}⁷ units, can be isolated by treating [Fe(CO)₂(NO)₂] with PS2H₂ (PS2H₂ = bis(2-dimercaptophenyl)phenylphosphine). Crystallographic studies reveal the syn-configuration of NO units and the bridging thiolates in the butterfly shape of the 2Fe2S core. Addition of PPh₃ to the solution of dinuclear 1 leads to the formation of mononuclear {FeNO}⁷ [Fe(NO)(PS2)(PPh₃)] (2) that shows electrochemical responses similar to those of 1. One-electron reduction of 1 with Cp*₂Co or KC₈ results in the isolation of thiolate-bridged bimetallic DNIC, [(PS2)Fe(μ-PS2)Fe(NO)₂]^- ([3]^-), confirmed by several spectroscopies including single-crystal X-ray diffraction studies. The bimetallic DNIC [3]^- is a rare example obtained from the one-electron reduction of a dinuclear Fe-NO {FeNO}⁷ model complex. With the assistance of redox behaviors of 2, electrochemical studies imply that the reduction of 1 leads to the formation of a mononuclear {FeNO}⁸ [Fe(NO)(PS2)(THF)]^- intermediate, which involves disproportionation or NO^- transfer to yield [3]^-. Based on IR data and magnetic properties, the electronic structure of [3]^- can be described as a Fe^II/{Fe(NO)₂}⁹ state. Isolation of the {Fe(NO)₂}⁹ moiety coordinated by the Fe ancillary complex lends strong support to the NO scrambling behavior in the effectiveness of the activity of flavodiiron nitric oxide reductases (FNORs).

Near-Infrared Light-Triggered Nitric Oxide Nanogenerators for NO-Photothermal Synergistic Cancer Therapy

Cancer is still one of the major health issues faced by human beings today. Various nanomaterials have been designed to treat tumors and have made great progress. Herein, we used amino-functionalized metal organic framework (UiO-66-NH₂) as superior templates and successfully synthesized the UiO-66-NH₂@Au_shell composite nanoparticles (UA) with high loading capacity and excellent photothermal properties through a simple and gentle method. In addition, due to the rich pore structure and excellent biocompatibility of the as-prepared composite nanoparticles, the hydrophobic NO donor BNN6 (N,N′-Di-sec-butyl-N,N′-dinitroso-1, 4-phenylenediamine) molecule was efficiently delivered. Based on the phenomenon where BNN6 molecules can decompose and release NO at high temperature, when UiO-66-NH₂@Au_shell-BNN6 composite nanoparticles (UA-BNN6) entered tumor cells and were irradiated by NIR, the porous gold nanoshells on the surface of composite nanoparticles induced an increase in temperature through the photothermal conversion process and promoted the decomposition of BNN6 molecules, releasing high concentration of NO, thus efficiently killing HeLa cells through the synergistic effect of NO-photothermal therapy. This effective, precise and safe treatment strategy controlled by NIR laser irradiation represents a promising alternative in the field of cancer treatment.